Search Results 521-530 of 2976 for ⚔[광고텔레:ADSFIX01] 바카라커뮤니티광고 대포장홍보 파워볼솔루션광고 개인장업체 카지노API 구글머니상홍보 노래방광고 토토디비광고 구글상단도배광고 상위노출대행⚔

1. A Study of the Safety, Pharmacodynamics, Effectiveness, and PK of TIMP-GLIA in Subjects with Celiac Disease - Mayo Clinic

   The purpose of this study is to evaluate participants for immune responses and histological changes in the small bowel following 2 doses of TIMP-GLIA or placebo ...

2. Patient Outcomes following Artificial Urinary Sphincter Placement in Male Patients - Mayo Clinic

   About this study. The purpose of this study is to create a Mayo Clinic AUS research database with follow-up through 4 months. To eventually evaluate other ...

3. A Study of Secukinumab Compared to Ustekinumab for Treatment of Patients with Plaque Psoriasis - Mayo Clinic

   The purpose of this study is to assess the long-term safety, tolerability, and effectiveness of secukinumab over ustekinumab for the treatment of patients who ...

4. Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - Mayo Clinic

   About this study. This randomized phase II/III trial studies how well temozolomide and veliparib work and compare them to temozolomide alone in treating ...

5. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis - Mayo Clinic

   The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy ...

6. Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer - Mayo Clinic

   About this study. This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can ...

7. Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies - Mayo Clinic

   The purpose of this study is to determine the maximum tolerated dose (MTD), activity, and safety of oprozomib in patients with hematologic malignancies.

8. The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4) - Mayo Clinic

   LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with ...

9. Faculty - Mayo Clinic Research

   The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...

10. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

    About this study. Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, ...